Cover Image

Sarcopenia as a prognostic indicator of liver cirrhosis

Saved in:

Bibliographic Details
Main Authors:	Sung‐Eun Kim (Author), Dong Joon Kim (Author)
Format:	Book
Published:	Wiley, 2022-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China
by: Xin Zeng, et al.
Published: (2021)

Inflammatory biomarkers as prognostic indicators for liver cirrhosis
by: Naglaa Abou-Elfattah Tawfik, et al.
Published: (2019)

The sex‐specific prognostic utility of sarcopenia in cirrhosis
by: Ryan Lowe, et al.
Published: (2022)

Impact of sarcopenia on the survival of patients undergoing liver transplantation for decompensated liver cirrhosis
by: Da Zhou, et al.
Published: (2023)

Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score
by: Seong Hee Kang, et al.
Published: (2018)

Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis
by: Benard Aliwa, et al.
Published: (2023)

Clinical outcomes and prognostic factors of mortality in liver cirrhosis patients on continuous renal replacement therapy in two tertiary hospitals in Korea
by: You Hyun Jeon, et al.
Published: (2021)

Prognostic value of serum autotaxin in liver cirrhosis and prediction of hepatocellular carcinoma
by: Nagwa Ramadan Ahmed, et al.
Published: (2019)

Prognostic indicators and risk factors for the in-hospital mortality rate of patients with cirrhosis
by: Zahra Shokati Eshkiki, et al.
Published: (2024)

Angiogenesis in liver cirrhosis and hepatocellular carcinoma
by: Amarapurkar Anjali, et al.
Published: (2008)

Skeletal Muscle Mitochondrial Impairment in Cirrhosis-Induced Sarcopenia
by: Omid Farshad, et al.
Published: (2020)

Liver Specific Serum Micro RNA122 as a Prognostic Marker in Egyptian Patients with Liver Cirrhosis
by: Mona A Amin, et al.
Published: (2017)

Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020)

Upper GI Bleed in a Patient With Cirrhosis of the Liver
by: Paul Kim, et al.
Published: (2015)

Liver Cirrhosis Update and Current Challenges
Published: (2017)

Liver Cirrhosis Debates and Current Challenges
Published: (2019)

Sarcopenia and frailty combined increases the risk of mortality in patients with decompensated cirrhosis
by: Gaoyue Guo, et al.
Published: (2022)

Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey
by: Joon Ho Moon, et al.
Published: (2021)

Hyponatremia - unfavourable prognostic factor in hepatic cirrhosis
by: Enescu Aurelia, et al.
Published: (2016)

VALUE OF AMINOTRANSFERASES IN LIVER CIRRHOSIS
by: Miroslava Mihaylova, et al.
Published: (2024)

Macrophage cytotherapy on liver cirrhosis
by: Dabing Ping, et al.
Published: (2023)

EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2017)

Assessment of Pyroptosis-Related Indicators as Potential Biomarkers and Their Association with Severity in Patients with Liver Cirrhosis
by: Wang D, et al.
Published: (2021)

Effects of Isosakuranetin on Pharmacokinetic Changes of Tofacitinib in Rats with <i>N</i>-Dimethylnitrosamine-Induced Liver Cirrhosis
by: Sung Hun Bae, et al.
Published: (2022)

Liver Cirrhosis in Woman with Ciliopathy Syndrome
by: Syifa Mustika, et al.
Published: (2022)

Newer Investigations in the diagnosis of cirrhosis of liver
by: Rajkumar Prannath Wadhwa, et al.
Published: (2022)

Complex pathogenetic treatment of liver cirrhosis
by: O. F. Dzygal, et al.
Published: (2017)

Complex pathogenetic treatment of liver cirrhosis
by: O. F. Dzygal, et al.
Published: (2017)

Liver Cirrhosis of the Viral Etiology in Children
by: F. I. Inoyatova, et al.
Published: (2018)

Quality of Life of Patients with Liver Cirrhosis
by: María Belén Alvarado Villavicencio, et al.
Published: (2023)

Relationship between sarcopenia/myosteatosis and frailty in hospitalized patients with cirrhosis: a sex-stratified analysis
by: Hongjuan Feng, et al.
Published: (2021)

Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non‐small‐cell lung cancer
by: Shinya Tanaka, et al.
Published: (2021)

Intestinal permeability in a patient with liver cirrhosis
by: Aguirre Valadez JM, et al.
Published: (2016)

Alcoholic liver cirrhosis: a systematic review
by: Poliana Noronha Barroso, et al.
Published: (2005)

A review of liver fibrosis and cirrhosis regression
by: Michael J. Lee
Published: (2023)

Impact of sarcopenia and phase angle on mortality of the very elderly
by: Young Eun Kwon, et al.
Published: (2023)

Blood Indices Replace Upper Gastrointestinal Endoscopy for the Prediction of Clinically Significant Esophageal Varices in Liver Cirrhosis
by: Venkatakrishna Sankapithlu, et al.
Published: (2021)

Efficacy and Safety of Ascites Treatment in Liver Cirrhosis
by: G. A. Ignatenko, et al.
Published: (2022)

Microbiota and Long-Term Prognosis in Liver Cirrhosis
by: E. G. Malaeva, et al.
Published: (2024)

Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis
by: Hiroki Nishikawa, et al.
Published: (2015)